Please login to the form below

Not currently logged in
Email:
Password:

Sophia Genetics appoints CFO

Valentin Matillon joins firm from the Hobart Group

Data-driven medicine firm Sophia Genetics has appointed its new chief financial officer in the form of Valentin Matillon.

He brings over two decades worth of experience in senior financial management positions to the group, holding roles in technology organisations including SITA, Hewlett-Packard and Electronic Arts.

He said: “Our ground breaking technology and approach are revolutionising the healthcare field, improving the prognosis of patients worldwide and I look forward to supporting the company through its journey of growth and development.”

Matillon joins Sophia Genetics from the Hobart Group, where he served as senior director of finance.

His new role will see him take responsibility for the company’s finance and accounting functions.

Jurgi Camblong, chief executive officer and co-founder of Sophia Genetics, said: “Matillon’s track record in transforming finance functions and supporting new acquisitions, along with his pragmatic and results-driven approach, make him a natural fit for the fast-paced culture of Sophia Genetics.”

19th January 2018

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics